Industries
Sectors and facility types.
Sterile manufacturing, oral solid dosage, biotechnology and laboratories each set different requirements for containment, cleanliness and utilities. The engineering basis is defined per sector and per product.
Sector index
Engineering for regulated facilities.
Each sector carries its own product risks, cleanliness requirements and utility demands. The engineering basis is set accordingly.
- 01Pharmaceutical ManufacturingOral solid, liquid, and semi-solid dosage production facilities.
- 02Sterile ManufacturingAseptic filling and terminally sterilized injectable facilities.
- 03BiotechnologyCell culture, fermentation, and biologics process facilities.
- 04LaboratoriesQuality control, microbiology, and analytical laboratory facilities.
- 05Medical DevicesAssembly, cleanroom packaging, and sterilization for device production.
- 06Healthcare FacilitiesHospital pharmacies, compounding units, and clinical support spaces.
- 07NutraceuticalsSupplement production in powders, capsules, tablets, and liquids.
- 08CosmeticsCreams, liquids, and powders under hygienic, controlled manufacturing.
- 09Warehousing & DistributionTemperature-controlled storage and GDP-oriented distribution facilities.
- 10R&D FacilitiesFormulation, pilot-scale, and clinical-supply facilities.
- 11Compounding PharmacySterile, non-sterile and hazardous compounding facilities engineered around workflow, containment and readiness.
- 12Hazardous Drug Handling FacilitiesContainment-led areas for receiving, storing, compounding, and disposing of hazardous drugs.
- 13QC & Microbiology LaboratoriesQuality control and microbiology laboratories with segregated testing environments.
Sector requirements
Engineering focus by sector.
- 01
Pharmaceutical Manufacturing
- Granulation, compression, and coating suite layout
- Dust containment and cross-contamination control
- Pressure cascades and airlocks between process rooms and corridors
- Purified water, compressed air, and process utility distribution
- 02
Sterile Manufacturing
- Cleanroom zoning from the Grade A/B aseptic core to Grade C/D support areas, with isolator or RABS integration
- Pressure cascades, airlocks, and pass-throughs that protect the aseptic core, with gowning sequences built into the route
- HVAC with terminal HEPA filtration, unidirectional airflow over critical zones, and smoke-study readiness
- WFI generation, recirculating distribution, and clean steam for sterilization and product-contact uses
- Environmental monitoring (EMS) points and a validation approach defined during design
- 03
Biotechnology
- Upstream and downstream segregation and flow separation
- Single-use versus stainless-steel process strategy
- Biosafety containment and inactivation of waste streams
- CIP/SIP, WFI, and clean steam distribution
- 04
Laboratories
- Fume hood and biosafety cabinet exhaust balancing
- Separation of microbiology, chemistry, and stability zones
- Specialist gas, vacuum, and laboratory water distribution
- Service zones sized for instrument changes
- 05
Medical Devices
- Cleanroom classification matched to assembly and packaging steps
- Interfaces with EtO, gamma, or steam sterilization routes
- Electrostatic discharge (ESD) and particulate control at workstations
- Segregated flows for components, work in progress, and finished goods
- 06
Healthcare Facilities
- Sterile compounding and cytotoxic preparation units
- Positive and negative pressure isolation rooms
- Infection-control zoning and clean/dirty flow separation
- Phased works within operational buildings
- 07
Nutraceuticals
- Allergen and botanical material segregation
- Dust extraction and explosion risk assessment for fine powders
- Hygienic finishes and cleanable room construction
- Upgrade path toward pharmaceutical GMP zoning
- 08
Cosmetics
- Mixing vessel, transfer piping, and CIP layout
- Purified water quality and distribution loop design
- Filling and packing line layout and changeover
- Cleanliness zoning scaled to microbiological risk
- 09
Warehousing & Distribution
- Receiving, quarantine, released, rejected, and returned stock segregation with controlled access
- Temperature-controlled zones, cold rooms, 2–8 °C stores, and backup refrigeration
- HVAC capacity and air distribution matched to racking height, loading, and seasonal extremes
- Separate storage provisions for flammable, hazardous, and high-risk materials
- Continuous temperature and humidity monitoring with alarms, laid out to support temperature mapping
- 10
R&D Facilities
- Modular laboratory and pilot suite planning for changing programs
- Clear boundaries between development and GMP clinical-supply zones
- Flexible utility drops and spare service capacity
- Facility provisions that keep the scale-up path to commercial production open
- 11
Compounding Pharmacy
- Segregation of non-sterile, sterile and hazardous compounding activities
- Personnel, material and waste routes planned from receipt to dispatch
- Classification concept, pressure relationships, airlocks and pass boxes
- HVAC zoning, exhaust and containment matched to each activity
- Environmental monitoring, commissioning and qualification readiness
- 12
Hazardous Drug Handling Facilities
- Dedicated receiving and unpacking areas with negative-pressure hazardous storage
- Containment PECs (BSC or CACI) in negative-pressure buffer rooms with external exhaust
- Separate entry, PPE donning and doffing, and access control
- Provisions for deactivation, decontamination, cleaning, and spill response
- A segregated hazardous waste route, with holding and dispatch areas
- 13
QC & Microbiology Laboratories
- Separation of microbiology, sterility testing, and chemical analysis zones
- Dedicated HVAC so that laboratory air is not shared with production areas
- A classified sterility-testing environment with a BSC or isolator and its own gowning route
- Sample, media, personnel, and waste flows, including decontamination before disposal
- Laboratory water, gases, washing areas, and controlled storage for media and reagents
Next step
Planning a pharmaceutical project?
Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.
+20 101 171 1700
